Dearborn Partners LLC Abbott Laboratories Transaction History

Dearborn Partners LLC

  • $2.42 Billion
  • Q3 2024

A detailed history of Dearborn Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dearborn Partners LLC holds 285,697 shares of ABT stock, worth $32.5 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
285,697
Previous 290,969 1.81%
Holding current value
$32.5 Million
Previous $30.2 Million 7.73%
% of portfolio
1.35%
Previous 1.32%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$100.07 - $118.13 $527,569 - $622,781
-5,272 Reduced 1.81%
285,697 $32.6 Million
Q2 2024

Jul 26, 2024
SELL
$100.73 - $112.44 $132,661 - $148,083
-1,317 Reduced 0.45%
290,969 $30.2 Million
Q1 2024

May 08, 2024
SELL
$109.52 - $120.96 $7.72 Million - $8.53 Million
-70,488 Reduced 19.43%
292,286 $33.2 Million
Q4 2023

Jan 26, 2024
SELL
$90.19 - $110.4 $493,790 - $604,440
-5,475 Reduced 1.49%
362,774 $39.9 Million
Q3 2023

Nov 01, 2023
SELL
$95.53 - $114.62 $140,046 - $168,032
-1,466 Reduced 0.4%
368,249 $35.7 Million
Q2 2023

Aug 03, 2023
SELL
$100.78 - $112.29 $214,963 - $239,514
-2,133 Reduced 0.57%
369,715 $40.3 Million
Q1 2023

May 04, 2023
SELL
$96.86 - $114.01 $29,251 - $34,431
-302 Reduced 0.08%
371,848 $37.7 Million
Q4 2022

Feb 02, 2023
SELL
$95.06 - $111.52 $856,775 - $1.01 Million
-9,013 Reduced 2.36%
372,150 $40.9 Million
Q3 2022

Oct 25, 2022
SELL
$96.76 - $112.03 $44,219 - $51,197
-457 Reduced 0.12%
381,163 $36.9 Million
Q2 2022

Jul 20, 2022
BUY
$102.07 - $123.37 $18,474 - $22,329
181 Added 0.05%
381,620 $41.5 Million
Q1 2022

May 04, 2022
BUY
$114.02 - $139.04 $100,793 - $122,911
884 Added 0.23%
381,439 $45.1 Million
Q4 2021

Jan 28, 2022
SELL
$115.53 - $141.46 $343,239 - $420,277
-2,971 Reduced 0.77%
380,555 $53.6 Million
Q3 2021

Oct 27, 2021
BUY
$116.66 - $129.06 $67,662 - $74,854
580 Added 0.15%
383,526 $45.3 Million
Q2 2021

Jul 26, 2021
BUY
$105.79 - $124.53 $361,907 - $426,017
3,421 Added 0.9%
382,946 $44.4 Million
Q1 2021

Apr 29, 2021
BUY
$108.84 - $128.23 $544,308 - $641,278
5,001 Added 1.34%
379,525 $45.5 Million
Q4 2020

Jan 27, 2021
BUY
$105.0 - $114.42 $27.9 Million - $30.4 Million
265,994 Added 245.09%
374,524 $41 Million
Q3 2020

Oct 20, 2020
BUY
$91.64 - $111.29 $8,614 - $10,461
94 Added 0.09%
108,530 $11.8 Million
Q2 2020

Jul 30, 2020
BUY
$76.57 - $98.0 $534,305 - $683,844
6,978 Added 6.88%
108,436 $9.91 Million
Q1 2020

May 11, 2020
BUY
$62.82 - $91.86 $119,734 - $175,085
1,906 Added 1.91%
101,458 $8.01 Million
Q4 2019

Jan 28, 2020
BUY
$78.51 - $87.4 $531,355 - $591,523
6,768 Added 7.29%
99,552 $8.65 Million
Q3 2019

Oct 29, 2019
SELL
$81.84 - $88.74 $51,559 - $55,906
-630 Reduced 0.67%
92,784 $7.76 Million
Q2 2019

Jul 29, 2019
BUY
$72.88 - $85.0 $2.07 Million - $2.41 Million
28,342 Added 43.55%
93,414 $7.86 Million
Q1 2019

May 01, 2019
SELL
$66.22 - $80.06 $314,280 - $379,964
-4,746 Reduced 6.8%
65,072 $5.2 Million
Q4 2018

Feb 04, 2019
BUY
$65.56 - $74.27 $284,464 - $322,257
4,339 Added 6.63%
69,818 $5.05 Million
Q3 2018

Oct 24, 2018
BUY
$60.81 - $73.36 $332,569 - $401,205
5,469 Added 9.11%
65,479 $4.8 Million
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $28,669 - $31,642
-498 Reduced 0.82%
60,010 $3.66 Million
Q1 2018

May 01, 2018
SELL
$56.27 - $63.62 $59,758 - $67,564
-1,062 Reduced 1.72%
60,508 $3.63 Million
Q4 2017

Feb 02, 2018
SELL
$53.68 - $57.47 $21,472 - $22,988
-400 Reduced 0.65%
61,570 $3.51 Million
Q3 2017

Nov 13, 2017
SELL
$48.06 - $53.64 $11,630 - $12,980
-242 Reduced 0.39%
61,970 $3.31 Million
Q2 2017

Aug 09, 2017
BUY
N/A
62,212
62,212 $3.02 Million

Others Institutions Holding ABT

# of Institutions
3,187
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email